Cargando…

Geolocalisation of athletes for out-of-competition drug testing: ethical considerations. Position statement by the WADA Ethics Panel

Through the widespread availability of location-identifying devices, geolocalisation could potentially be used to place athletes during out-of-competition testing. In light of this debate, the WADA Ethics Panel formulated the following questions: (1) should WADA and/or other sponsors consider fundin...

Descripción completa

Detalles Bibliográficos
Autores principales: Borry, Pascal, Caulfield, Timothy, Estivill, Xavier, Loland, Sigmund, McNamee, Michael, Knoppers, Bartha Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867440/
https://www.ncbi.nlm.nih.gov/pubmed/29500253
http://dx.doi.org/10.1136/bjsports-2017-098299
_version_ 1783308965666357248
author Borry, Pascal
Caulfield, Timothy
Estivill, Xavier
Loland, Sigmund
McNamee, Michael
Knoppers, Bartha Maria
author_facet Borry, Pascal
Caulfield, Timothy
Estivill, Xavier
Loland, Sigmund
McNamee, Michael
Knoppers, Bartha Maria
author_sort Borry, Pascal
collection PubMed
description Through the widespread availability of location-identifying devices, geolocalisation could potentially be used to place athletes during out-of-competition testing. In light of this debate, the WADA Ethics Panel formulated the following questions: (1) should WADA and/or other sponsors consider funding such geolocalisation research projects?, (2) if successful, could they be proposed to athletes as a complementary device to Anti-Doping Administration and Management System to help geolocalisation and reduce the risk of missed tests? and (3) should such devices be offered on a voluntary basis, or is it conceivable that they would be made mandatory for all athletes in registered testing pools? In this position paper, the WADA Ethics Panel concludes that the use of geolocalisation could be useful in a research setting with the goal of understanding associations between genotype, phenotype and environment; however, it recognises that the use of geolocalisation as part of or as replacement of whereabouts rules is replete with ethical concerns. While benefits remain largely hypothetical and minimal, the potential invasion of privacy and the data security threats are real. Considering the impact on privacy, data security issues, the societal ramifications of offering such services and various pragmatic considerations, the WADA Ethics Panel concludes that at this time, the use of geolocalisation should neither be mandated as a tool for disclosing whereabouts nor implemented on a voluntary basis.
format Online
Article
Text
id pubmed-5867440
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-58674402018-03-27 Geolocalisation of athletes for out-of-competition drug testing: ethical considerations. Position statement by the WADA Ethics Panel Borry, Pascal Caulfield, Timothy Estivill, Xavier Loland, Sigmund McNamee, Michael Knoppers, Bartha Maria Br J Sports Med Consensus Statement Through the widespread availability of location-identifying devices, geolocalisation could potentially be used to place athletes during out-of-competition testing. In light of this debate, the WADA Ethics Panel formulated the following questions: (1) should WADA and/or other sponsors consider funding such geolocalisation research projects?, (2) if successful, could they be proposed to athletes as a complementary device to Anti-Doping Administration and Management System to help geolocalisation and reduce the risk of missed tests? and (3) should such devices be offered on a voluntary basis, or is it conceivable that they would be made mandatory for all athletes in registered testing pools? In this position paper, the WADA Ethics Panel concludes that the use of geolocalisation could be useful in a research setting with the goal of understanding associations between genotype, phenotype and environment; however, it recognises that the use of geolocalisation as part of or as replacement of whereabouts rules is replete with ethical concerns. While benefits remain largely hypothetical and minimal, the potential invasion of privacy and the data security threats are real. Considering the impact on privacy, data security issues, the societal ramifications of offering such services and various pragmatic considerations, the WADA Ethics Panel concludes that at this time, the use of geolocalisation should neither be mandated as a tool for disclosing whereabouts nor implemented on a voluntary basis. BMJ Publishing Group 2018-04 2018-03-02 /pmc/articles/PMC5867440/ /pubmed/29500253 http://dx.doi.org/10.1136/bjsports-2017-098299 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Consensus Statement
Borry, Pascal
Caulfield, Timothy
Estivill, Xavier
Loland, Sigmund
McNamee, Michael
Knoppers, Bartha Maria
Geolocalisation of athletes for out-of-competition drug testing: ethical considerations. Position statement by the WADA Ethics Panel
title Geolocalisation of athletes for out-of-competition drug testing: ethical considerations. Position statement by the WADA Ethics Panel
title_full Geolocalisation of athletes for out-of-competition drug testing: ethical considerations. Position statement by the WADA Ethics Panel
title_fullStr Geolocalisation of athletes for out-of-competition drug testing: ethical considerations. Position statement by the WADA Ethics Panel
title_full_unstemmed Geolocalisation of athletes for out-of-competition drug testing: ethical considerations. Position statement by the WADA Ethics Panel
title_short Geolocalisation of athletes for out-of-competition drug testing: ethical considerations. Position statement by the WADA Ethics Panel
title_sort geolocalisation of athletes for out-of-competition drug testing: ethical considerations. position statement by the wada ethics panel
topic Consensus Statement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867440/
https://www.ncbi.nlm.nih.gov/pubmed/29500253
http://dx.doi.org/10.1136/bjsports-2017-098299
work_keys_str_mv AT borrypascal geolocalisationofathletesforoutofcompetitiondrugtestingethicalconsiderationspositionstatementbythewadaethicspanel
AT caulfieldtimothy geolocalisationofathletesforoutofcompetitiondrugtestingethicalconsiderationspositionstatementbythewadaethicspanel
AT estivillxavier geolocalisationofathletesforoutofcompetitiondrugtestingethicalconsiderationspositionstatementbythewadaethicspanel
AT lolandsigmund geolocalisationofathletesforoutofcompetitiondrugtestingethicalconsiderationspositionstatementbythewadaethicspanel
AT mcnameemichael geolocalisationofathletesforoutofcompetitiondrugtestingethicalconsiderationspositionstatementbythewadaethicspanel
AT knoppersbarthamaria geolocalisationofathletesforoutofcompetitiondrugtestingethicalconsiderationspositionstatementbythewadaethicspanel